T3 for the Treatment of Fibromyalgia
Dr. Ian Carroll, MD, MS, and Dr. Jarred Younger, PhD , of the Stanford Systems Neuroscience and Pain Lab are currently enrolling patients for a clinical trial investigating T3 for the treatment of fibromyalgia.
Fibromyalgia Symptoms
The primary complaint of those with fibromyalgia is widespread body pain and muscle tenderness. Most people who have fibromyalgia also experience fatigue and have trouble sleeping. They may also complain of concentration or memory problems, gastrointestinal issues, headaches, and muscle weakness.
Role of T3
We are investigating whether the thyroid hormone T3 is one such treatment that may alleviate the symptoms of Fibromyalgia. There is significant overlap between the symptoms ofhypothyroidism (low thyroid hormone production), depression, chronic fatigue, and Fibromyalgia. Patients with low thyroid hormone production who have been treated with T3 for depression have had some improvement in symptoms.
Studies such as this are a necessary step to having an investigational drug become a mainstream treatment. Your participation is a vital part of the search for an effective Fibromyalgia treatment.
For more information about the study, including eligibility criteria, follow the link below to the study information page, or download the study brochure.
If you are interested in participating, please complete the secure screening survey by clicking on the link below.
